Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 58Observational 3Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 9Carcinoma, Hepatocellular 9Gastrointestinal Stromal Tumors 7Carcinoma, Non-Small-Cell Lung 7Stomach Neoplasms 6Ovarian Neoplasms 6Liver Neoplasms 6Cholangiocarcinoma 6Prostatic Neoplasms 5Breast Neoplasms 5Melanoma 4Sarcoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Neuroblastoma 2Neoplasms 2Hepatoblastoma 2Glioblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Wounds and Injuries 1Wilms Tumor 1Uveal Melanoma 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Wilms Tumor × Gastrointestinal × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡